LACTATED RINGERS INJECTION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Lactated Ringers Injection Market, By Formulation (Standard Lactated Ringers Solution and Lactated Ringers with Additives), By Volume (250 mL, 500 mL, and 1000 mL), By Age Group (Adults, Pediatrics, and Geriatrics), By Container (Plastic Bottles, PVC Bags, and Glass Bottles/Vials etc.), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

On November 12, 2024, ICU Medical, a medical technology company, has been expanding its global footprint, especially in emerging markets where healthcare infrastructure is rapidly growing. By increasing access to its infusion systems and IV solutions like lactated ringers injection, ICU Medical is well-positioned to meet the rising demand for critical care products in these regions.
In April 2024, Baxter, a S.-based multinational healthcare company, expanded its pharmaceuticals portfolio with five new injectable products in the U.S., launched on April 11, 2024. The products include Norepinephrine, Vasopressin, Vancomycin, Ropivacaine, and Regadenoson, all available in ready-to-use formulations. These innovations aim to improve patient safety and streamline healthcare processes by reducing contamination risks and preparation errors. The new products focus on critical therapeutic areas such as hypotension, infections, anesthesia, and stress testing.

Product Recall Update:

In May 2020, ICU Medical, Inc. medical technology company voluntarily recalled a specific lot of Lactated Ringers Injection, USP, due to the detection of iron oxide particulate matter. This recall was initiated following a customer complaint. The affected product was distributed nationwide for both human and veterinary use. At the time of the recall, no adverse events had been reported.